VIA
REPL icon

Vident Investment Advisory’s Replimune Group REPL Stock Holding History

Vident Investment Advisory’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26,161
Closed -$462K – 1319
2023
Q1 		$462K Sell
26,161
-902
-3% -$21.4K 0.02% 808
2022
Q4 		$736K Sell
27,063
-15,146
-36% -$315K 0.03% 579
2022
Q3 		$729K Sell
42,209
-4,524
-10% -$86.3K 0.02% 679
2022
Q2 		$817K Buy
46,733
+1,654
+4% +$27.2K 0.02% 693
2022
Q1 		$765K Buy
45,079
+7,515
+20% +$142K 0.02% 797
2021
Q4 		$1.02M Sell
37,564
-6,483
-15% -$194K 0.03% 700
2021
Q3 		$1.31M Sell
44,047
-3,146
-7% -$102K 0.04% 588
2021
Q2 		$1.81M Buy
47,193
+9,431
+25% +$323K 0.06% 449
2021
Q1 		$1.15M Sell
37,762
-171
-0.5% -$6.4K 0.04% 576
2020
Q4 		$1.45M Sell
37,933
-22,419
-37% -$934K 0.06% 419
2020
Q3 		$1.39M Sell
60,352
-4,148
-6% -$94.5K 0.07% 398
2020
Q2 		$1.6M Buy
+64,500
New +$1.14M 0.08% 281

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vident Investment Advisory's REPL Position: Q2 2023 in Review

Vident Investment Advisory sold out of Replimune Group (REPL) in Q2 2023, closing a stake of 26,161 shares — an estimated $462K sold.

Vident Investment Advisory first reported a position in REPL in Q2 2020 and held it in 12 quarters. The position peaked at $1.81M in Q2 2021. 141 funds tracked by Wall St. Rank hold REPL as of Q2 2023.

  • Vident Investment Advisory reported no remaining Replimune Group position as of Q2 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 26,161 Replimune Group shares in Q2 2023, an estimated $462K.
  • Vident Investment Advisory first reported a position in Replimune Group in Q2 2020 and held it in 12 quarters.
  • Vident Investment Advisory's Replimune Group position peaked at $1.81M in Q2 2021.
  • 141 funds tracked by Wall St. Rank held Replimune Group as of Q2 2023.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.